EUVIMEDOpdag EUVIMED
Crossref

Can sarcopenia predict survival in locally advanced rectal cancer patients?

Richard Gartrell iD, Jing Qiao iD, Nicole Kiss, Ian Faragher, Steven Chan, Paul N Baird, Justin M Yeung iD

ANZ Journal of Surgery · 2023

DOI: 10.1111/ans.18512 ↗

At a glance

Journal article in ANZ Journal of Surgery, 2023. Written by Richard Gartrell and 6 co-authors. Institution: Department of Colorectal Surgery, Western Health, Melbourne, Victoria, Australia. Major MEDLINE topics: Sarcopenia, Rectal Neoplasms. Cited 17 times so far (Crossref); 24 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

There is mounting evidence that suggests sarcopenia can be used to predict survival outcomes in patients with colon cancer. However, the effect on locally advanced rectal cancer (LARC) is less clear. We sought to determine the association between sarcopenia on Overall Survival and Recurrence‐free Survival (OS and RFS) in patients with LARC undergoing multimodal treatment.

Methods

A retrospective study was undertaken of all pre‐treatment stage 2–3 rectal cancer patients who underwent neo‐adjuvant treatment and surgery with curative intent between January 2010 and September 2016 at Western Health. Sarcopenia was measured on pre‐treatment staging scans at the third lumbar vertebrae and defined using cohort‐derived, sex‐specific thresholds. Primary outcomes were OS and RFS.

Results

A total of 132 patients with LARC were analysed. Sarcopenia: Hazard ratio (HR) 3.71; 95% CI, 1.28–10.75, P = 0.016 was independently associated with worse Overall Survival following multivariate analysis. There was no significant relationship between sarcopenia and RFS: Time ratio (TR) 1.67; 95% CI 0.52–5.34, P = 0.386.

Conclusion

Sarcopenia was found to be an independent risk factor for worse overall survival, but not recurrence free survival, in patients with locally advanced rectal cancer undergoing neo‐adjuvant chemo‐radiotherapy and surgery with curative intent.

Subjects

MeSH terms (MEDLINE)

SarcopeniaRectal NeoplasmsMaleFemaleHumansRetrospective StudiesChemotherapy, AdjuvantCombined Modality TherapyPrognosisNeoadjuvant Therapy

Author keywords

muscle massneo-adjuvant chemo-radiotherapyrectal cancersarcopeniasurvival

Authors and institutions

  • Department of Colorectal Surgery, Western Health, Melbourne, Victoria, Australia.
  • Department of Surgery (Western Precinct), University of Melbourne, Melbourne, Victoria, Australia.
  • Institute for Physical Activity and Nutrition, Deakin University, Melbourne, Victoria, Australia.
  • Allied Health Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Department of Surgery, Ophthalmology, University of Melbourne, Melbourne, Victoria, Australia.

ORCID profiles: Richard Gartrell, Jing Qiao, Justin M Yeung

Cite

APA

Gartrell, R., Qiao, J., Kiss, N., Faragher, I., Chan, S., Baird, P. N., & Yeung, J. M. (2023). Can sarcopenia predict survival in locally advanced rectal cancer patients?. ANZ Journal of Surgery. https://doi.org/10.1111/ans.18512

Vancouver

Gartrell R, Qiao J, Kiss N, Faragher I, Chan S, Baird PN, et al. Can sarcopenia predict survival in locally advanced rectal cancer patients?. ANZ Journal of Surgery. 2023. doi:10.1111/ans.18512

BibTeX
@article{Gartrell2023,
  author = {Gartrell, Richard and Qiao, Jing and Kiss, Nicole and Faragher, Ian and Chan, Steven and Baird, Paul N and Yeung, Justin M},
  title = {Can sarcopenia predict survival in locally advanced rectal cancer patients?},
  journal = {ANZ Journal of Surgery},
  year = {2023},
  doi = {10.1111/ans.18512}
}
Start for free →